Siga Technologies Inc.

SIGA Healthcare Drug Manufacturers Specialty & Generic

Siga Technologies Inc.’s revenue for fiscal 2025 (year ended December 2025) was $94.6 million, down 31.8% from fiscal 2024. In the quarter to June 2026, revenue fell 49.5%, EPS fell 66.0% and free cash flow fell 76.0%, each against the same quarter a year earlier. Dividend growth for five consecutive years.

3.17 0.02 −0.63%
Market cap
$229.2M
P/E
0.0×
Fwd P/E
28.7×
Dividend yield
0.00%
F-score
5/9
Altman Z
14.28
Beneish M
−4.02
Dividend safety
36/100

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Total current assets
212.86 231.04 238.99 185.79 208.75 143.61 180.04 121.29 37.36 69.16
Total non-current assets
6.61 13.29 15.36 9.25 5.97 6.22 18.52 82.15 107.31 91.82
Total Assets
219.47 244.34 254.35 195.04 214.73 149.83 198.57 203.44 144.67 160.98
Total current liabilities
17.99 25.33 54.12 21.52 30.49 10.48 91.74 11.34 6.81 7.10
Total non-current liabilities
2.65 3.20 3.38 3.36 9.92 9.55 9.05 89.19 461.00 441.30
Total liabilities
20.65 28.53 57.49 24.88 40.41 20.04 100.78 100.53 467.81 448.40
Common Equity (Total)
198.82 215.80 196.86 170.16 174.31 129.79 97.78 102.91 (323.14) (287.42)
Shareholders Equity (Total)
198.82 215.80 196.86 170.16 174.31 129.79 97.78 102.91 (323.14) (287.42)
Total Debt
— — — 2.03 2.57 2.35 80.04 75.55 71.05 66.55

Show all line items

In millions of $ except per-share values · columns are period end dates